Skip to Content

MYLAN G 13 (Glimepiride 4 mg)

Pill imprint MYLAN G 13 has been identified as Glimepiride 4 mg.

Glimepiride is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glimepiride 4 mg is not a controlled substance under the Controlled Substance Act (CSA).

Glimepiride 4 mg MYLAN G 13
Glimepiride 4 mg MYLAN G 13
Glimepiride 4 mg MYLAN G 13
Glimepiride
Imprint:
MYLAN G 13
Strength:
4 mg
Color:
Beige
Size:
10.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4013
Inactive Ingredients:
lactose monohydrate
magnesium stearate
microcrystalline cellulose
povidone
sodium lauryl sulfate
sodium starch glycolate type A potato
D&C Red No. 27
D&C Yellow No. 10
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0426 UDL Laboratories Inc

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide